With the monkeypox vaccine being in excessive demand and available doses being devoured up by rich international locations, Jamaica is about to obtain simply 3,500 doses by month-finish.
Minister of Health and Wellness, Dr Christopher Tufton offered the replace throughout Tuesday’s sitting of the House of Representatives. He stated the acquisition is being facilitated by collaboration with the Pan American Health Organisation (PAHO) which introduced this week that it has secured 100,000 doses from the Danish producers.
“We are advised that the manufacturers of the smallpox vaccine that has been shown to be effective in protecting persons from moneypox has supplied limited amounts to the market and, as such, only approximately 3,500 doses of the vaccine have been promised to us. It is to be noted that we may not receive this amount, as the supply of the vaccine is in high demand with very limited supply,” Tufton stated.
He stated that so as to maximise the use of the vaccine and obtain the aims of containment, Cabinet has given approval for administering the vaccine on this section, as a submit-publicity prophylaxis.
“The vaccine, once in country, will be administered only to persons who come into close contact with a diagnosed patient. These persons would include healthcare workers involved in direct care of monkeypox patients… and household contacts of confirmed cases, to include sexual partners,” Tufton defined
He added that after the nation receives extra doses of the vaccine, the prioritisation technique might be refined, and the general public might be suggested.
“We have been advised by PAHO that it is not anticipated that additional doses will be made available to Jamaica before 2023,” the minister disclosed.
Meanwhile, PAHO Director, Dr Carissa Etienne, stated the organisation is finalising preparations for the acquisition of the 100,000 doses of the monkeypox vaccines from biotechnology agency Bavarian Nordic, for distribution to Latin American and Caribbean member international locations.
Etienne stated PAHO secured an settlement by its Revolving Fund facility, with Bavarian Nordic, which is headquartered in Hellerup, Denmark. She stated this adopted requests from member international locations for help in accessing doses, which have been made throughout a particular session of the PAHO Directing Council in August, noting that 12 such have been submitted.
“We are receiving the final logistical details, such as estimates for freight and insurance, and the deliveries will be prioritised based on the epidemiological situation in countries. So partial delivery to countries that requested will start, now, in September… making our region the first World Health Organisation (WHO) region to make monkeypox vaccines available to member states,” Etienne additional knowledgeable.
“Our effort will permit countries in this region to access the vaccine, even in small quantities, which would not have been possible otherwise,” she added.
The director was talking throughout PAHO’s digital media briefing on September 7 the place she famous that the area of the Americas has the unenviable distinction of recording the best quantity of confirmed monkeypox circumstances globally, because the WHO declared the illness a well being emergency of worldwide concern in July.
“As of September 6, over 30,000 monkeypox cases have been reported in the Americas, with most cases concentrated in the United States of America, Brazil, Peru and Canada. Thus far, most confirmed cases are among men… although at least 145 cases have been reported in women, and 54 cases among people under the age of 18,” she advised journalists.
Additionally, the director stated 4 monkeypox-related deaths have, up to now, been reported in Brazil, Cuba and Ecuador.
Monkeypox is a uncommon illness ensuing from an infection by the monkeypox virus. The monkeypox virus is a zoonotic illness and is a component of the household of viruses often called variola virus, which causes smallpox.
The signs are related to these attribute of smallpox, however milder; monkeypox is deemed not often deadly.
The indicators and signs related to the illness embrace fever, chills, intense headache, excessive exhaustion, muscle and backaches, swollen lymph nodes and a rash that often seems one to three days after the onset of the fever.